Sangro B, Melero I, Yau T, et al. Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. AAASLD 2017, Presidential Poster of Distinction 141.
Ho radio-embolisatie na PRRT met Lu-dotataat bij patiënten met NET-levermetastasen
mei 2020 | Maag-darm-leveroncologie